Showing 5,281 - 5,300 results of 77,879 for search '(( 50 ((mean decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( a e decrease ))', query time: 1.33s Refine Results
  1. 5281

    lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy by Qingqing Meng (1613494)

    Published 2020
    “…Long non-coding RNA zinc finger E-box binding homeobox 1 antisense 1 (ZEB1-AS1) plays a crucial role in the development of various diseases, including DN. …”
  2. 5282
  3. 5283
  4. 5284

    Potential signatures of adaptive introgression at <i>SLC30A9</i>. by Ana Roca-Umbert (17041620)

    Published 2023
    “…The red dot denoted the <i>SLC30A9</i> region. (D) Joint distribution of the U (10%, 50%, 100%) and Q95 (10%, 100%) statistics in CEU and CHB when using either YRI or ESN as unadmixed group. …”
  5. 5285

    DataSheet_2_The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.csv by Bixia Yang (18550324)

    Published 2024
    “…The renal composite outcomes were defined as: (1) ESRD, defined as eGFR < 15 ml/(min·1.73 m<sup>2</sup>) or initiation of renal replacement therapy (hemodialysis, peritoneal dialysis, renal transplantation); (2) serum creatinine doubled from baseline; (3) eGFR decreased by more than 50% from baseline. …”
  6. 5286

    DataSheet_1_The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.docx by Bixia Yang (18550324)

    Published 2024
    “…The renal composite outcomes were defined as: (1) ESRD, defined as eGFR < 15 ml/(min·1.73 m<sup>2</sup>) or initiation of renal replacement therapy (hemodialysis, peritoneal dialysis, renal transplantation); (2) serum creatinine doubled from baseline; (3) eGFR decreased by more than 50% from baseline. …”
  7. 5287
  8. 5288
  9. 5289
  10. 5290
  11. 5291
  12. 5292
  13. 5293
  14. 5294
  15. 5295
  16. 5296

    Epigenetic adaptation of the placental serotonin transporter gene (<i>SLC6A4</i>) to gestational diabetes mellitus by Sofia Blazevic (4173319)

    Published 2017
    “…<div><p>We tested the hypothesis that gestational diabetes mellitus (GDM) alters the DNA methylation pattern of the fetal serotonin transporter gene (<i>SLC6A4</i>), and examined the functional relevance of DNA methylation for regulation of the <i>SLC6A4</i> expression in the human placenta. …”
  17. 5297
  18. 5298
  19. 5299
  20. 5300